Benson Hill (BHILQ)
OTHER OTC:BHILQ
Want to see BHILQ full AI Analyst Report?
Top Page
Rating:―N/A
Price Target:―
Action:N/ADate:―
No summary available
Positive Factors
Innovative Business Model
Benson Hill's innovative approach using its CropOS platform positions it to capitalize on trends in sustainable agriculture, offering a competitive edge in developing nutritious and sustainable food solutions.
Negative Factors
High Leverage
High leverage can strain financial flexibility and increase risk, potentially limiting the company's ability to invest in growth opportunities and weather economic downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Innovative Business Model
Benson Hill's innovative approach using its CropOS platform positions it to capitalize on trends in sustainable agriculture, offering a competitive edge in developing nutritious and sustainable food solutions.
Read all positive factors
Benson Hill (BHILQ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$611.00
Dividend YieldN/A
Average Volume (3M)6.01K
Price to Earnings (P/E)―
Beta (1Y)-26456.97
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees270
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,114,020
10 Day Avg. Volume6,117
30 Day Avg. Volume6,006
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.38
Price to Sales (P/S)0.07
P/FCF Ratio-0.39
Enterprise Value/Market Cap212.77K
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit12.54
Enterprise Value/Ebitda-2.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Benson Hill Business Overview & Revenue Model
Company Description
Benson Hill, Inc., together with its subsidiaries, operates as a food technology company that unlocks natural genetic diversity of plants. It operates in two segments, Ingredients and Fresh. The company offers CropOS, a technology platform, which ...
How the Company Makes Money
Benson Hill generates revenue primarily through its proprietary CropOS platform and its associated plant breeding and biotechnology services. The company earns money by developing and licensing improved crop varieties, which are designed to enhanc...
Benson Hill Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 205.82M | 473.34M | 381.23M | 147.21M | 59.07M | 79.52M |
| Gross Profit | 10.36M | 23.63M | 3.53M | -945.00K | 4.65M | 8.56M |
| EBITDA | -57.48M | -54.77M | -56.01M | -109.09M | -50.37M | -39.91M |
| Net Income | -101.77M | -115.31M | -127.91M | -126.25M | -64.52M | -43.91M |
Balance Sheet | ||||||
| Total Assets | 137.54M | 274.76M | 500.92M | 534.90M | 231.78M | 96.74M |
| Cash, Cash Equivalents and Short-Term Investments | 14.41M | 48.68M | 157.17M | 182.65M | 110.08M | 10.93M |
| Total Debt | 94.40M | 145.83M | 187.64M | 165.73M | 65.42M | 18.70M |
| Total Liabilities | 110.70M | 188.72M | 307.02M | 283.45M | 99.10M | 45.04M |
| Stockholders Equity | 26.84M | 86.04M | 193.90M | 251.45M | 132.68M | 51.70M |
Cash Flow | ||||||
| Free Cash Flow | -40.20M | -84.89M | -109.88M | -149.24M | -62.53M | -51.19M |
| Operating Cash Flow | -38.02M | -73.13M | -93.40M | -117.75M | -52.68M | -44.35M |
| Investing Cash Flow | 131.46M | 118.03M | -40.25M | -154.59M | -100.67M | -4.55M |
| Financing Cash Flow | -119.08M | -72.14M | 98.01M | 341.56M | 160.70M | 48.55M |
Benson Hill Technical Analysis
Negative
0.01
Price Trends
0.01
Negative
0.03
Negative
Market Momentum
>-0.01
Negative
44.05
Neutral
0.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BHILQ, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 44.05 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BHILQ.
Benson Hill Risk Analysis
Benson Hill disclosed 59 risk factors in its most recent earnings report. Benson Hill reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Benson Hill Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | $611.00 | ― | ― | ― | ― | ― | |
46 Neutral | $14.33M | -1.23 | ― | ― | -19.66% | -317.00% | |
43 Neutral | $2.18M | -1.16 | -80.74% | ― | -8.58% | 66.90% | |
42 Neutral | $30.34M | -0.11 | -105.50% | ― | -30.08% | -4391.74% | |
40 Underperform | $81.34M | -2.18 | -22.89% | ― | -5.88% | 60.63% |
* Basic Materials Sector Average
BHILQ
Benson Hill
0.01
-0.05
-83.33%
AVD
American Vanguard
2.85
-1.37
-32.46%
SEED
Origin Agritech
1.18
-0.10
-7.81%
RKDA
Arcadia Biosciences
1.06
-2.44
-69.71%
BIOX
Bioceres Crop Solutions
0.48
-3.77
-88.73%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―